ChiCGB vs BEAM in High-risk or R/R Lymphomas

NCT05466318 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

306

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma, Large B-Cell, Diffuse
Lymphoma, T-Cell

Interventions

DRUG: Chidamide
DRUG: Cladribine
DRUG: Gemcitabine
DRUG: Busulfan
DRUG: Carmustine
DRUG: Etoposide
DRUG: Cytarabine
DRUG: Melphalan
PROCEDURE: Autologous hematopoietic stem cell transplant

Sponsor

Sichuan University